Yondelis 1 mg powder for concentrate for solution for infusion. clinical trials

Phase I-II prospective trial, multicenter, open label, exploring the combination of Trabectedin plus RAdiotherapy in Soft Tissue Sarcoma patients

This study looks at combining a chemotherapy drug called Yondelis with radiotherapy for people with a type of cancer called soft tissue sarcoma. It aims to find the safest and most effective dose of Yondelis when used with radiotherapy, and to see if this combination can help stop the cancer from coming back.